CSIC has developed a new chiral zeolitic material for the asymmetric synthesis of chiral chemical products. The material has a chiral structure (ITV) with a very high porosity (with extra-large pore openings, 4.3 x 19.3 Å) and active centers, which allows the catalytic enantioselective processing of large size molecules, reaching enantiomeric excesses in model reactions much [read more]
CSIC, Autonomous University of Madrid and the University of Castilla la Mancha, have developed a photocatalyst composed of nanoparticles of titanium oxide and graphene, for the degradation of organic contaminants in aqueous solutions, using sunlight as activation source. Industrial partners interested in licensing the material for its development and commercialization, for water decontamination, are sought
Authors: [read more]
CSIC has developed a new method for hydrogen production through methanol reforming using a photo-thermo-catalyst, which combines thermal and light energy for the activation. The method allows to moderate the operating conditions (temperature and pressure), leading to energy savings and an improvement in the stability of the catalyst.
Industrial partners from the energetic industry interested in using [read more]
CSIC, IISA, IACS, the University of Zaragoza and ARAID have discovered a natural compound with antiviral capacity against the virus that causes hepatitis C. The compound is extracted from a natural and edible source, non-toxic and cheap and shows a virus inhibition capacity superior to that of commercial drugs currently used in the treatment of this [read more]
The CSIC has developed a compact and desktop device for macro enlargement photography by stacking photographs, ready to be placed on any work table. It is universal because it accepts and is configured to use a set of lenses and microscope lenses, so that you can obtain high quality photographs [read more]
Aqueous extract with anti-hypertensive, anti-hyperlipidemic, anti-hypercholesterolemic and antioxidant properties
CSIC has developed a method of extracting spirulina biocomponents that possess high anti-hypertensive, anti-hyperlipidemic and antioxidant activity for use in the food, cosmetic or pharmaceutical industry.
Companies interested in patent licensing are sought for the development of these biocomponents as marketable products.